"These results suggest that anti-obesity medication use, with relatively safe, effective, and sustainable weight loss, may be ...

Patients who have significant weight loss with anti-obesity medications after joint replacement show reductions in the risk for revision; however, caution on their use is urged as patients recover.

For patients with obesity undergoing joint replacement, higher weight loss after initiating antiobesity medications ...

"Greater weight loss within a year of starting anti-obesity medications was linked to a lower risk of joint replacement ...

Higher weight loss after initiating antiobesity meds linked to lower risk for revision of hip and knee replacement. HealthDay News — For patients with obesity undergoing joint replacement ...

Even slight weight loss spurred on by cutting-edge GLP-1 drugs can help prevent replacement knees and hips from wearin ...

When Jennie Garth announced she'd had not one but two hip replacements-the first at age 48 and the second in 2024 at 52-the ...

The results were similar when the analyses were performed separately for hip or knee replacement. The hazard ratios for revision were 0.55 (95% CI: 0.32 to 0.93) and 0.49 (95% CI: 0.25 to 0.97 ...

Published results showed patients with obesity who took anti-obesity medications and had postoperative weight loss within 1 ...

A study finds that weight loss after joint replacement surgery, aided by anti-obesity medications, reduces the risk of ...